Capital Research Global Investors Qiagen N.V. Transaction History

Capital Research Global Investors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$35.99 - $39.39 $78.3 Million - $85.7 Million	-2,176,055 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$31.23 - $37.47 $5,558 - $6,669	178 Added 0.01%	2,176,055 $79.3 Million
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $67.5 Million - $71.7 Million	2,175,877	2,175,877 $68.5 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.